Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Toloza

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Lupus|April 5, 2013
Spanish LupusPRO: cross-cultural validation study for lupusM Jolly, S Toloza, J Block, et al.
Annals of the Rheumatic Diseases|November 5, 2005
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control studyJ Calvo-Alén, G McGwin, S Toloza, et al.
Clinical Rheumatology|January 18, 2020
International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settingsM Elmamoun, M Eraso, M Anderson, et al.
Clinical and Experimental Rheumatology|January 6, 2011
Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA databaseA Naranjo, S Toloza, I Guimaraes da Silveira, et al.
Annals of the Rheumatic Diseases|August 1, 2009
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA databaseT Sokka, H Kautiainen, T Pincus, et al.
Lupus|November 18, 2024
Current smoking is related to severe damage in systemic lupus erythematosus patientsM A Cosatti, S A Muñoz, M T Tamborenea, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Lupus|April 5, 2013
Spanish LupusPRO: cross-cultural validation study for lupusM Jolly, S Toloza, J Block, et al.
Annals of the Rheumatic Diseases|November 5, 2005
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control studyJ Calvo-Alén, G McGwin, S Toloza, et al.
Clinical Rheumatology|January 18, 2020
International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settingsM Elmamoun, M Eraso, M Anderson, et al.
Clinical and Experimental Rheumatology|January 6, 2011
Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA databaseA Naranjo, S Toloza, I Guimaraes da Silveira, et al.
Annals of the Rheumatic Diseases|August 1, 2009
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA databaseT Sokka, H Kautiainen, T Pincus, et al.
Lupus|November 18, 2024
Current smoking is related to severe damage in systemic lupus erythematosus patientsM A Cosatti, S A Muñoz, M T Tamborenea, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 2